一个新型的肠球菌菌体Endolysin Lys22具有广泛的宿主范围,可以抵抗Enterococcus faecalis,Staphylococcus aureus和Acinetobacter baumannii的混合生物膜
Ziqin Yang1, Xue Du2, Nannan Hu1
1Department of Pathogenobiology, College of Basic Medical Science, Jilin University, Changchun 130021, China.
Pathogens (Basel, Switzerland)
|October 29, 2025
概括
Lys22,一种内素,有效地向多种耐药细菌,如菌,金黄色葡萄球菌和Acinetobacter baumannii. 这种菌体衍生物抑制生物膜并对抗混合感染,提供了一种新的抗微生物策略.
科学领域:
- 微生物学与传染病的研究
- 抗微生物耐药性 抗微生物耐药性
- 细菌治疗疗法是一种细菌治疗.
背景情况:
- 多抗药性 (MDR) 细菌病原体,包括Enterococcus faecalis,Staphylococcus aureus和Acinetobacter baumannii,是一个日益严重的全球健康问题,经常导致医院获得的感染.
- 这些细菌形成弹性生物膜,通过抵抗常规抗生素和免疫反应,导致治疗失败.
- 菌体及其衍生物,如内素,正在成为对抗抗生素耐药细菌的有希望的替代品.
研究的目的:
- 为了评估Lys22的疗效,一种来自肠球菌的内溶素,对关键的多药耐药细菌病原体.
- 评估Lys22在抑制简单和复杂细菌生物膜中的活性.
- 研究Lys22在治疗混合细菌感染中的潜在治疗应用.
主要方法:
- 克隆和描述Lys22,一个具有广泛宿主范围的内溶素.
- 在体外评估Lys22对E. faecalis,S. aureus和A. baumannii.形成的生物膜的抑制作用.
- 在Lys22治疗后对毒性基因表达的分析 (例如,agrA,sarA,icaA,asa1,cylA,gelE,OmpA,lpsB).
- 在双重或三重细菌感染的斑马鱼胚胎模型中对Lys22的体内疗效测试.
主要成果:
- Lys22 显示出针对 E. faecalis,S. aureus 和 A. baumannii 的广泛活性.
- 在体外,Lys22显著抑制了简单和复杂生物膜的形成和结构.
- 22治疗导致了检测细菌物种中关键毒性基因的下调.
- 在斑马鱼胚胎模型中,Lys22对致命的双重和三重感染提供了显著的保护.
结论:
- 莱斯22是一种强大的内溶酶,对临床相关的多药耐药细菌及其生物膜有效.
- lys22通过抑制生物膜形成和降低毒性因子来表现出双重的作用机制.
- Lys22 显示出作为治疗复杂,多微生物感染由耐药病原体引起的治疗剂的前景.
关键词:
这种细菌是Acinetobacter baumannii.菌 (Enterococcus faecalis) 是一种菌.黄金葡萄球菌黄金葡萄球菌复合生物膜是一种复合生物膜.恩多利辛 (endolysin) 是一种内分离剂.多种药物耐药性多种药物耐药性更多相关视频
07:47Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
12.0K
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
3.2K
相关概念视频
01:30Lytic Cycle of Bacteriophages
77.4K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.4K
01:26DNA Bacteriophages
790
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
790
01:20Viral Replication: Lytic Cycle
1.2K
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
1.2K
00:43Lysogenic Cycle of Bacteriophages
67.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.3K